ChiCTR2000041287 版本V1.2 版本创建时间2021/03/06 16:07:52 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2000041287 

最近更新日期:

Date of Last Refreshed on:

2021-03-06 16:07:16 

注册时间:

Date of Registration:

2020-12-23 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

初学者及带教老师肠镜检查时各肠段退镜时间与ADR的关系研究

Public title:

Improving trainees’ and/or teachers‘ colonoscopy performance by investigating the withdrawal time from individual colonic segment

注册题目简写:

English Acronym:

研究课题的正式科学名称:

初学者及带教老师肠镜检查时各肠段退镜时间与ADR的关系研究

Scientific title:

Improving trainees’ and/or teachers‘ colonoscopy performance by investigating the withdrawal time of individual colonic segments

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

陈聪颖 

研究负责人:

陈聪颖 

Applicant:

Congying Chen 

Study leader:

Congying Chen 

申请注册联系人电话:

Applicant telephone:

+86 18116149147

研究负责人电话:

Study leader's telephone:

+86 18116149147

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

cherrychencong@163.com

研究负责人电子邮件:

Study leader's E-mail:

cherrychencong@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市虹口区海宁路100号

研究负责人通讯地址:

上海市虹口区海宁路100号

Applicant address:

100 Haining Road, Hongkou District, Shanghai, China

Study leader's address:

100 Haining Road, Hongkou District, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海市第一人民医院

Applicant's institution:

Shanghai General Hospital

研究负责人所在单位:

上海市第一人民医院

Affiliation of the Leader:

Shanghai General Hospital

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2020科042

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

上海市第一人民医院人体试验伦理审查委员会

Name of the ethic committee:

Shanghai General Hospital Institutional Review Board

伦理委员会批准日期:

Date of approved by ethic committee:

2020-07-31 00:00:00

伦理委员会联系人:

马磊

Contact Name of the ethic committee:

Lei Ma

伦理委员会联系地址:

上海市虹口区海宁路100号行政楼317伦理办公室

Contact Address of the ethic committee:

Room 317, Administration Building, Shanghai General Hospital, 100 Haining Road, Hongkou District, Shanghai, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海市第一人民医院

Primary sponsor:

Shanghai General Hospital

研究实施负责(组长)单位地址:

上海市虹口区海宁路100号

Primary sponsor's address:

100 Haining Road, Hongkou District, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市第一人民医院

具体地址:

虹口区海宁路100号

Institution
hospital:

Shanghai General Hospital

Address:

100 Haining Road, Hongkou District

经费或物资来源:

上海市第一人民医院

Source(s) of funding:

Shanghai General Hospital

Target disease:

colorectal cancer

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

回顾性研究 

Study phase:

Retrospective study

研究设计:

析因分组(即根据危险因素或暴露因素分组) 

Study design:

Factorial 

研究目的:

研究初学者及带教老师肠镜检查时退镜时间与各肠段adr/pdr的关系。  

Objectives of Study:

We analyzed the relationship between colonoscopic WT and ADR/polyp detection rate (PDR) in proximal, left-sided and the entire colon for trainees and teachers.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

上海市第一人民医院内镜中心由6位初学者及3位带教老师操作的肠镜。

Inclusion criteria

Patients who underwent screening colonoscopy by 6 trainees and 3 teachers in Endoscopy Center of Shanghai General Hospital.

排除标准:

1,急诊肠镜;2.肠梗阻;3,结肠手术史;4,肠镜下治疗;5.ibd,6,遗传性息肉综合症;7,肠道准备极差;8,小于18岁或大于80岁;9,无法识别肝曲或脾曲结构。

Exclusion criteria:

(1) Emergency colonoscopy;
(2) colonic obstruction;
(3) previous history of colonic operations;
(4) planned therapeutic procedure (including polypectomy);
(5) surveillance of inflammatory bowel disease;
(6) hereditary polyposis syndrome;
(7) unacceptable bowel preparation (solid);
(8) patients older than age 80 years or younger than age 18 years;
(9) those in whom it was difficult to identify the hepatic flexure and/or splenic flexure.

研究实施时间:

Study execute time:

From 2020-12-10 00:00:00 To 2020-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-12-10 00:00:00 To 2020-12-31 00:00:00  

干预措施:

Interventions:

组别:

第一组

样本量:

100

Group:

colonoscopy

Sample size:

干预措施:

初学者A操作

干预措施代码:

Intervention:

colonoscopy by trainee A

Intervention code:

组别:

第二组

样本量:

100

Group:

colonoscopy

Sample size:

干预措施:

初学者B操作

干预措施代码:

Intervention:

colonoscopy by trainee B

Intervention code:

组别:

第三组

样本量:

100

Group:

colonoscopy

Sample size:

干预措施:

初学者C操作

干预措施代码:

Intervention:

colonoscopy by trainee C

Intervention code:

组别:

第四组

样本量:

100

Group:

colonoscopy

Sample size:

干预措施:

初学者D操作

干预措施代码:

Intervention:

colonoscopy by trainee D

Intervention code:

组别:

第五组

样本量:

100

Group:

colonoscopy

Sample size:

干预措施:

初学者E操作

干预措施代码:

Intervention:

colonoscopy by trainee E

Intervention code:

组别:

第六组

样本量:

100

Group:

colonoscopy

Sample size:

干预措施:

初学者F操作

干预措施代码:

Intervention:

colonoscopy by trainee F

Intervention code:

组别:

第七组

样本量:

100

Group:

colonoscopy

Sample size:

干预措施:

老师A操作

干预措施代码:

Intervention:

colonoscopy by teacher A

Intervention code:

组别:

第八组

样本量:

100

Group:

colonoscopy

Sample size:

干预措施:

老师B操作

干预措施代码:

Intervention:

colonoscopy by teacher B

Intervention code:

组别:

第九组

样本量:

100

Group:

colonoscopy

Sample size:

干预措施:

老师C操作

干预措施代码:

Intervention:

colonoscopy by teacher C

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海 

市(区县):

 

Country:

China 

Province:

Shanghai 

City:

 

单位(医院):

上海市第一人民医院 

单位级别:

三级甲等 

Institution
hospital:

Shanghai General Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

腺瘤检出率

指标类型:

主要指标

Outcome:

ADR

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

息肉检出率

指标类型:

主要指标

Outcome:

PDR

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 80 years

性别:

男性

Gender:

Male

随机方法(请说明由何人用什么方法产生随机序列):

随机

Randomization Procedure (please state who generates the random number sequence and by what method):

random sampling

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

发邮件至cherrychencong@163.com,要求共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

you can email to cherrychencong@163.com, then I will send to you.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF表汇总到excel

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF and excel

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2020-12-23 11:04:40